BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22767635)

  • 1. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.
    Morgan CL; Jenkins-Jones S; Currie CJ; Rees DA
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3251-60. PubMed ID: 22767635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study.
    Berni TR; Morgan CL; Rees DA
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3369-e3380. PubMed ID: 34061968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
    Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
    J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
    Lo JC; Feigenbaum SL; Yang J; Pressman AR; Selby JV; Go AS
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1357-63. PubMed ID: 16434451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.
    Schmidt J; Landin-Wilhelmsen K; Brännström M; Dahlgren E
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3794-803. PubMed ID: 21956415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome.
    De Frène V; Vansteelandt S; T'Sjoen G; Gerris J; Somers S; Vercruysse L; De Sutter P
    Hum Reprod; 2014 Oct; 29(10):2333-8. PubMed ID: 24963163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
    Legro RS; Kunselman AR; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
    Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.
    Wild S; Pierpoint T; McKeigue P; Jacobs H
    Clin Endocrinol (Oxf); 2000 May; 52(5):595-600. PubMed ID: 10792339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cardiocerebrovascular diseases is increased in Korean women with polycystic ovary syndrome: a nationwide cohort study.
    Ryu KJ; Park H; Kim MS; Jeong HG; Kim T
    Sci Rep; 2024 Jan; 14(1):1055. PubMed ID: 38212642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
    Talbott EO; Zborowskii JV; Boudraux MY
    Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
    Velija-Asimi Z; Burekovic A; Dujic T; Dizdarevic-Bostandzic A; Semiz S
    Bosn J Basic Med Sci; 2016 Nov; 16(4):298-306. PubMed ID: 27648989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome.
    Rubin KH; Glintborg D; Nybo M; Abrahamsen B; Andersen M
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3848-3857. PubMed ID: 28938447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
    Carmina E; Campagna AM; Lobo RA
    Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess mortality in mothers of patients with polycystic ovary syndrome.
    Louwers YV; Roest-Schalken ME; Kleefstra N; Roeters van Lennep J; van den Berg M; Fauser BC; Bilo HJ; Sijbrands EJ; Laven JS
    Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.